Citations

Clear

4799 citation(s) found for "Yu, Jennifer".

Mitochondrial Metabolic Dysregulation and Structural Abnormalities in a Rat Model of Polycystic Kidney Disease
Arroyo, Jennifer, Zhang, Song , Dzeja, Petras P. , Irazabal, María V. , Vučković, Ivan , Macura, Slobodan , Harris, Peter C. , Torres, Vicente E.

Mayo Clinic

The FASEB Journal | November 26, 2023 | Volume: 31 | Issue: S1 | Pages: No page available

10.1096/fasebj.31.1_supplement.1032.3 Get It

Background Autosomal Dominant Polycystic Kidney Disease (PKD) is the most frequent hereditary renal disease and the fourth leading cause of end‐stage renal disease. However, the exact mechanisms of cystogenesis and disease progression remain to be elucidated. Recent evidence suggests that a metabolic reprograming may underlie the dysregulation of several signaling pathways known to be affected in PKD. To identify the metabolic pathways associated with cystogenesis in the PKD kidney, we characterized the urinary, plasma, and tissue metabolome of PCK (a well established model of PKD) compared to Sprague‐Dawley (SD) wild‐type rats. Methods Male and female PCK and SD rats were treated with dDAVP (PCK‐D, n=16 or SD‐D, n=12) to aggravate the cystic phenotype and achieve animals with different degrees of disease severity for a given age, or saline solution (PCK‐S, n=16 or SD‐S, n=12) as controls. Total kidney volume (TKV) gold standard to assess disease severity, were measured by MRI, and urinary, plasma, and tissue metabolites by proton nuclear magnetic resonance, 1H‐NMR. Kidney metabolites identified from renal tissues collected at euthanasia were correlated with TKV. Mitochondrial structure was assessed by electron microscopy in proximal tubules (PT), medullary thick ascending limb (mTAL), distal tubules (DT), and collecting ducts (CD). Results Consistent with previously published data, administration of dDAVP significantly aggravated the disease in PCK rats (TKV) without inducing a cystic phenotype in SD rats (). Analysis of PCK and SD metabolomes by Partial least squares‐discriminant analysis (PLS‐DA) score plots showed a significant separation between the groups (). Integration of tissue, urine and plasma analysis revealed 5 metabolites (α‐ketoglutarate, fumarate, malate, citrate, and hippurate) consistently differentially expressed, among which 4 participate in the mitochondrial tricarboxylic acid (TCA) cycle (). Moreover, tissue TCA cycle metabolites correlated directly with TKV (). Mitochondrial area and matrix density were preserved in PT, mTAL, and DT of PCK rats, yet disruption of cristae membranes, swelling, and decreased matrix density were observed in their CD cystic cells (). Conclusions Comprehensive multilevel metabolomics analysis showed significant dysregulations of several mitochondrial TCA cycle metabolites in PCK rats, which further aggravated with the more severe phenotype. Notably, these changes were associated with mitochondrial structural abnormalities in the CD. Our observations suggest that mitochondrial damage and metabolic dysregulations may be implicated in cystogenesis, and position mitochondria as important therapeutic targets in PKD. Support or Funding Information This study was supported by the Mayo Translational Polycystic Kidney Disease Center (NIDDK P30 DK090728) and an endowment from Robert M. and Billie J. Pirnie for Kidney Research
ATP Maintains the Ability to Blunt α 1 ‐Adrenergic Vasoconstriction During Combined Blockade of Nitric Oxide, Prostaglandins, Na + /K
Richards, Jennifer C., Luckasen, Gary J. , Larson, Dennis G., Hearon, Christopher M. , Joyner, Michael J. , Dinenno, Frank A.

Mayo Clinic

The FASEB Journal | November 26, 2023 | Volume: 30 | Issue: S1 | Pages: No page available

10.1096/fasebj.30.1_supplement.752.4 Get It

The vasoactive properties of exogenous adenosine triphosphate (ATP) are unique because it has the dual ability to induce robust vasodilation as well as blunt sympathetic vasoconstriction, similar to what is observed in contracting human skeletal muscle. ATP‐mediated vasodilation and exercise hyperemia are dependent, in part, on activation of inwardly rectifying potassium (K IR ) channels and subsequent smooth muscle cell hyperpolarization, with a modest reliance on the production of nitric oxide (NO) and prostaglandins (PGs). However, recent studies from our laboratory indicate that these pathways are not obligatory for contracting skeletal muscle to blunt α 1 ‐adrenergic vasoconstriction. Given the specific role of K IR channels in ATP‐mediated vasodilation, the primary purpose of this study was to determine whether the ability of ATP to blunt α 1 ‐adrenergic vasoconstriction is dependent upon K IR channel activity in humans. A secondary purpose was to determine whether the ability of ATP to blunt α 1 ‐adrenergic vasoconstriction is dependent upon activation of K IR channels and Na + /K + ‐ATPase, as well as the synthesis of NO and PGs. In a total of 13 young subjects we measured forearm blood flow (Doppler ultrasound) and calculated changes in vascular conductance (FVC) to local intra‐arterial infusion of phenylephrine (PE; α 1 ‐agonist) during infusion of ATP or a control vasodilator(s) (Protocol 1 (n=7): adenosine (ADO), and sodium nitroprusside (SNP); Protocol 2 (n=6): ADO). Vasomotor responses were assessed before and after blockade of signaling pathways that contribute to ATP‐mediated vasodilation (Protocol 1: K IR channels (barium chloride); Protocol 2: combined blockade of K IR channels, Na + /K + ‐ATPase (ouabain), NO (L‐NMMA), PGs (Ketorolac)). Protocol 1: ATP significantly attenuated PE‐mediated vasoconstriction relative to both SNP and ADO (Δ FVC: ATP: −16 ± 2; ADO: −38 ± 6; SNP: −59 ± 6%; P<0.05 vs ADO and SNP). Blockade of K IR channels significantly attenuated ATP mediated vasodilation ~40% (P<0.05 vs. control), but had no effect on the ability of ATP to blunt PE‐ mediated vasoconstriction (Δ FVC: −6 ± 5%; P>0.05 vs. control). Protocol 2: Despite combined blockade of K IR , Na + /K + ‐ATPase, NO, and PGs resulting in profound attenuation of ATP‐mediated vasodilation (−~60%; P<0.01 vs. control), ATP was still able to blunt PE‐mediated vasoconstriction (Δ FVC: −4 ± 14%; P=0.50 vs. control). Together these studies highlight that while NO, PGs, and vascular smooth muscle hyperpolarization (via K IR channel activation) are contributors to the normal vasodilatory response to exercise and exogenous ATP, these pathways are not obligatory for exercise or ATP to blunt α 1 ‐adrenergic vasoconstriction in humans. Support or Funding Information Support: HL119337, HL095573
Amyloid and Tau PET Positivity in Progressive Agrammatic Aphasia and Apraxia of Speech
Pham, Nha Trang Thu, Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer L. , Tetzloff, Katerina A. , Duffy, Joseph R. , Clark, Heather M. , Machulda, Mary M. , Botha, Hugo , Jack, Clifford R. , Dickson, Dennis W. , Utianski, Rene L.

Mayo Clinic

Journal of Alzheimer's Disease | November 21, 2023 | Volume: 96 | Issue: 4 | Pages: 1759-1765

10.3233/jad-230912 | PMID 38007664 Get It

Background: The agrammatic variant of primary progressive aphasia (PAA), primary progressive apraxia of speech (PPAOS), or a combination of both (AOS-PAA) are neurodegenerative disorders characterized by speech-language impairments and together compose the AOS-PAA spectrum disorders. These patients typically have an underlying 4-repeat tauopathy, although they sometimes show evidence of amyloid-β and tau deposition on PET, suggesting Alzheimer’s disease (AD). Given the growing number of pharmacologic treatment options for AD, it is important to better understand the incidence of AD pathology in these patients. Objective: This study aimed to evaluate the frequency of amyloid-β and tau positivity in AOS-PAA spectrum disorders. Sixty-five patients with AOS-PAA underwent a clinical speech-language battery and PiB PET and flortaucipir PET imaging. Methods: Global PiB PET standardized uptake value ratios (SUVRs) and flortaucipir PET SUVRs from the temporal meta region of interest were compared between patient groups. For 19 patients who had died and undergone autopsy, their PET and pathology findings were also compared. Results: The results showed that although roughly half of the patients are positive for at least one biomarker, their clinical symptoms and biomarker status were not related, suggesting that AD is not the primary cause of their neurodegeneration. All but one patient in the autopsy subset had a Braak stage of IV or less, despite four being positive on tau PET imaging. Conclusions: Inclusion criteria for clinical trials should specify clinical presentation or adjust the evaluation of such treatments to be specific to disease diagnosis beyond the presence of certain imaging biomarkers.
Hospitalization Risk Associated With Emergency Department Reasons for Visit and Patient Age: A Retrospective Evaluation of National Emergency Department Survey Data to Help Identify Potentially Avoidable Emergency Department Visits
North, Frederick , Garrison, Gregory M. , Jensen, Teresa B. , Stroebel, Robert J. , Pecina, Jennifer , Stroebel, Robert , Pecina, Jennifer L.

Mayo Clinic

Health Services Research and Managerial Epidemiology | November 21, 2023 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/23333928231214169 | PMID 38023369 Get It

Background Patients often present to emergency departments (EDs) with concerns that do not require emergency care. Self-triage and other interventions may help some patients decide whether they should be seen in the ED. Symptoms associated with low risk of hospitalization can be identified in national ED data and can inform the design of interventions to reduce avoidable ED visits. Methods We used the National Hospital Ambulatory Medical Care Survey (NHAMCS) data from the United States National Health Care Statistics (NHCS) division of the Centers for Disease Control and Prevention (CDC). The ED datasets from 2011 through 2020 were combined. Primary reasons for ED visit and the binary field for hospital admission from the ED were used to estimate the proportion of ED patients admitted to the hospital for each reason for visit and age category. Results There were 221,027 surveyed ED visits during the 10-year data collection with 736 different primary reasons for visit and 23,228 hospitalizations. There were 145 million estimated hospitalizations from 1.37 billion estimated ED visits (10.6%). Inclusion criteria for this study were reasons for visit which had at least 30 ED visits in the sample; there were 396 separate reasons for visit which met this criteria. Of these 396 reasons for visit, 97 had admission percentages less than 2% and another 52 had hospital admissions estimated between 2% and 4%. However, there was a significant increase in hospitalizations within many of the ED reasons for visit in older adults. Conclusion Reasons for visit from national ED data can be ranked by hospitalization risk. Low-risk symptoms may help healthcare institutions identify potentially avoidable ED visits. Healthcare systems can use this information to help manage potentially avoidable ED visits with interventions designed to apply to their patient population and healthcare access.
Multilevel Implementation Strategies for Adolescent Human Papillomavirus Vaccine Uptake
MacLaughlin, Kathy L. , Jenkins, Gregory D. , MacLaughlin, Kathy, Jenkins, Gregory, Jacobson, Robert M. , Rutten, Lila J. Finney , Griffin, Joan M. , Sauver, Jennifer L. St. , Austin, Jessica D. , Herrin, Jeph

Mayo Clinic

JAMA Pediatrics | November 20, 2023 | Volume: 178 | Issue: 1 | Pages: 29

10.1001/jamapediatrics.2023.4932 | PMID 37983062 Get It

Trial RegistrationClinicalTrials.gov Identifier: NCT03501992
Machine Learning Identifies Smartwatch-Based Physiological Biomarker for Predicting Disruptive Behavior in Children: A Feasibility Study
Romanowicz, Magdalena , Croarkin, Kyle S., Elmaghraby, Rana, Skime, Michelle , Croarkin, Paul E. , Voort, Jennifer L. Vande , Shekunov, Julia , Athreya, Arjun P. , Vande Voort, Jennifer L , Croarkin, Paul E

Mayo Clinic

Journal of Child and Adolescent Psychopharmacology | November 15, 2023 | Volume: 33 | Issue: 9 | Pages: 387-392

10.1089/cap.2023.0038 | PMID 37966360 Get It

Objective: Parents frequently purchase and inquire about smartwatch devices to monitor child behaviors and functioning. This pilot study examined the feasibility and accuracy of using smartwatch monitoring for the prediction of disruptive behaviors. Methods: The study enrolled children ( N = 10) aged 7–10 years hospitalized for the treatment of disruptive behaviors. The study team completed continuous behavioral phenotyping during study participation. The machine learning protocol examined severe behavioral outbursts (operationalized as episodes that preceded physical restraint) for preparing the training data. Supervised machine learning methods were trained with cross-validation to predict three behavior states—calm, playful, and disruptive. Results: The participants had a 90% adherence rate for per protocol smartwatch use. Decision trees derived conditional dependencies of heart rate, sleep, and motor activity to predict behavior. A cross-validation demonstrated 80.89% accuracy of predicting the child's behavior state using these conditional dependencies. Conclusion: This study demonstrated the feasibility of 7-day continuous smartwatch monitoring for children with severe disruptive behaviors. A machine learning approach characterized predictive biomarkers of impending disruptive behaviors. Future validation studies will examine smartwatch physiological biomarkers to enhance behavioral interventions, increase parental engagement in treatment, and demonstrate target engagement in clinical trials of pharmacological agents for young children.
3D reconstruction of murine mitochondria reveals changes in structure during aging linked to the MICOS complex
Vue, Zer , Neikirk, Kit , Vang, Larry , Shao, Jianqiang, Crabtree, Amber , Murphy, Alexandria C. , Jenkins, Brenita C. , Prasad, Praveena , Evans, Chantell S. , Mungai, Margaret , Killion, Mason , Stephens, Dominique C., Christensen, Trace , Lam, Jacob , Phillips, Mark , Daneshgar, Nastaran , Koh, Ho‐Jin , Koh, Alice, Devine, Nina Garcia, Arnold, Kenneth R. , Chavarin, Valeria Vanessa , Robinson, Ryan Daniel , Gaddy, Jennifer A. , Sweetwyne, Mariya T. , Wilson, Genesis , Zaganjor, Elma , Kezos, James , Dondi, Cristiana , Reddy, Anilkumar K. , Quintana, Anita M. , Ocorr, Karen , Murray, Sandra , Exil, Vernat , Riggs, Blake , Mobley, Bret C. , Gómez, José A. , McReynolds, Melanie R. , Hinton, Antentor , Killion, Mason , Wilson, Genesis , Ocorr, Karen , Exil, Vernat , Hinton, Antentor , Murray, Sandra A , Lam, Jacob , Evans, Chantell S , Garza-López, Edgar , Katti, Prasanna , Beasley, Heather K. , Marshall, Andrea G. , Taylor, Brittany , Rodriguez, Benjamin, Davis, Jamaine S. , Saleem, Mohammad , Scudese, Estêvão , Chakraborty, Moumita , Glancy, Brian , Kirabo, Annet , Dai, Dao‐Fu , Damo, Steven M. , Gomez, Jose A.

Mayo Clinic

Aging Cell | November 14, 2023 | Volume: 22 | Issue: 12 | Pages: No page available

10.1111/acel.14009 | PMID 37960952 Get It

Abstract During aging, muscle gradually undergoes sarcopenia, the loss of function associated with loss of mass, strength, endurance, and oxidative capacity. However, the 3D structural alterations of mitochondria associated with aging in skeletal muscle and cardiac tissues are not well described. Although mitochondrial aging is associated with decreased mitochondrial capacity, the genes responsible for the morphological changes in mitochondria during aging are poorly characterized. We measured changes in mitochondrial morphology in aged murine gastrocnemius, soleus, and cardiac tissues using serial block‐face scanning electron microscopy and 3D reconstructions. We also used reverse transcriptase‐quantitative PCR, transmission electron microscopy quantification, Seahorse analysis, and metabolomics and lipidomics to measure changes in mitochondrial morphology and function after loss of mitochondria contact site and cristae organizing system (MICOS) complex genes, Chchd3 , Chchd6 , and Mitofilin . We identified significant changes in mitochondrial size in aged murine gastrocnemius, soleus, and cardiac tissues. We found that both age‐related loss of the MICOS complex and knockouts of MICOS genes in mice altered mitochondrial morphology. Given the critical role of mitochondria in maintaining cellular metabolism, we characterized the metabolomes and lipidomes of young and aged mouse tissues, which showed profound alterations consistent with changes in membrane integrity, supporting our observations of age‐related changes in muscle tissues. We found a relationship between changes in the MICOS complex and aging. Thus, it is important to understand the mechanisms that underlie the tissue‐dependent 3D mitochondrial phenotypic changes that occur in aging and the evolutionary conservation of these mechanisms between Drosophila and mammals.
PATH-33. MORPHOLOGY, MOLECULAR FEATURES, AND CLINICAL BEHAVIOR OF METHYLATION CLASS PLEOMORPHIC XANTHOASTROCYTOMA
Dampier, Chris, Shah, Niharika, Galbraith, Kirstyn, Rajan, Sharika, Robinson, Lorraina , Baker, Tiffany , Cathcart, Sahara , Alexandrescu, Sanda , Thomas-Ogunniyi, Jaiyeola , Pytel, Peter , Lopes, Beatriz, Conway, Kyle , Gregory, Jason V. , Abdullaev, Zied , Quezado, Martha , Aldape, Kenneth , Dampier, Christopher H. , Galbraith, Kirstyn, Vaubel, Rachael A. , Ketchum, Courtney , Costa, Felipe D’Almeida , Ferman, Sima , Neto, Osório Lopes Abath , Wadhwani, Nitin R. , Lee, Han, Mao, Qinwen , Marshall, Michael S. , Fernandes, Igor, Cotter, Jennifer A. , Gilani, Ahmed , McCord, Matthew , Thomas, Diana , Gregory, Jason, Andreiuolo, Felipe , Nirschl, Jeffrey , Giannini, Caterina , Snuderl, Matija

Mayo Clinic

Neuro-Oncology | November 11, 2023 | Volume: 25 | Issue: Supplement_5 | Pages: v175-v175

10.1093/neuonc/noad179.0663 Get It

Abstract Methylation profiling has revealed unexpected relationships between traditional histopathology-based versus biologically-based classifications of brain tumors. Methylation class pleomorphic xanthoastrocytoma (mcPXA) comprises tumors with the same methylation signature as classical PXA but with additional morphologic patterns, including overlap with glioblastoma (GBM). To characterize mcPXA, we examined epidemiologic, histologic, and molecular features as well as clinical behavior of a cohort (n=313) of tumors matching to mcPXA by the DKFZ classifier (v12 score &gt;= 0.85). Patient median age was 19 (range 1-73) with a female predominance (178 female/135 male). CDKN2A/B homozygous deletion was observed in 273 (87%) cases. In the subset of cases tested for BRAF p.V600E (n=120), 111 (93%) harbored the mutation. Concomitant chr7+/chr10- was observed in 66 (21%) cases. In the subset of cases tested for TERT promoter mutations (n=50), 11 (22%) harbored the mutation, always with co-occurrence of BRAF p.V600E (11/11) and infrequently with chr7+/chr10- (3/11). MGMT promoter methylation was observed in 40 (13%) cases. Overall and progression-free survival (OS, PFS) in mcPXA were similar to grade 2-3 IDH-mutant astrocytoma (A-IDH). Prognostic factors in mcPXA included GBM-like histopathology (defined as cases diagnosed as GBM prior to methylation profiling), concomitant chr7+/chr10-, and MGMT promoter methylation. GBM-like histopathology was associated with shorter OS (p=0.02) and PFS (p&lt; 0.01) compared to cases without GBM-like histopathology. Concomitant chr7+/chr10- was associated with shorter PFS (p=0.02), and MGMT promoter methylation was associated with shorter OS (p=0.03). Our findings demonstrate that mcPXA tumors affect adolescents and young adults, share molecular features of classical PXA, and manifest clinical behavior similar to classical PXA, but subsets of tumors with atypical features (chr7+/chr10-, MGMT promoter methylation, and/or GBM-like histopathology) are more aggressive. The use of a molecular definition of PXA reveals that this tumor type is more common than previously appreciated and warrants in-depth study for therapeutic options.
BIOM-51. IDENTIFICATION OF A LOW-FLIP ANGLE BASED CBV THRESHOLD FOR FRACTIONAL TUMOR BURDEN (FTB) MAPPING IN RECURRENT GLIOBLASTOMA
Anil, Aliya , Stokes, Ashley M. , Alhilali, Lea , Karis, John P. , Eschbacher, Jennifer , Hu, Leland , Quarles, C. Chad , Bell, Laura C. , Boxerman, Jerrold L. , Schmainda, Kathleen M

Mayo Clinic

Neuro-Oncology | November 11, 2023 | Volume: 25 | Issue: Supplement_5 | Pages: v15-v16

10.1093/neuonc/noad179.0062 Get It

Abstract INTRODUCTION Differentiation of glioblastoma recurrence from post treatment radiation effects (PTRE) would improve patient management. Dynamic susceptibility contrast (DSC) MRI can be used to generate fractional tumor burden (FTB) maps, via application of regional cerebral blood volume (RCBV) thresholds, to spatially differentiate recurrence from PTRE. FTB maps derived from a DSC-MRI protocol that includes a contrast agent preload in addition to the bolus injection and a moderate-flip angle (MFA) been histologically validated. Recently, a single-dose, low-flip angle (LFA) protocol was shown to provide RCBV measurements consistent with the MFA protocol and has been recommended as a consensus protocol. This study aims to identify the RCBV thresholds for the single-dose, LFA protocol that generates FTB maps, concordant with those obtained from the reference double-dose, MFA protocol. METHODS Two sets of DSC-MRI data were collected sequentially from 52 patients using a single-dose, low-flip angle (30o) protocol and a double-dose, moderate flip angle (60o) protocol using TR = 1.5s and TE = 30ms. Standardized RCBV maps (sRCBV) were obtained and co-registered with the post-contrast T1-weighted images using the FDA-approved clinical software, IB Neuro™ and IB Delta Suite™, respectively. The ground truth MFA-based FTB maps were computed using multiple sRCBV thresholds (1.0 and 1.75). An ROC analysis was conducted to identify the optimal, voxel-wise LFA sRCBV thresholds to produce FTB maps that best match the reference maps. RESULTS/ CONCLUSIONS The ROC analysis identified a lower LFA threshold of 1.0 to accurately distinguish PTRE from tumor recurrence and an upper threshold of 1.55 to differentiate aggressive tumor regions. The single-dose, LFA protocol eliminates variations in the contrast agent incubation time between the preload and bolus injection. This study provides motivation for the use of the single-dose LFA protocol in the management of patients with glioblastoma and is a reliable method for distinguishing tumor from PTRE.
TMIC-09. PRIMARY CILIA REGULATE EXTRACELLULAR VESICLE-MEDIATED IMMUNOSUPPRESSION IN HUMAN GLIOBLASTOMA CELLS
Trichka, Josie, Agyeman-Andoh, Afua, George, Jubin , Roehrkasse, Amanda M., Adoro, Stanley , Jung, Mi-Yeon, Oishi, Masahiro , Agyeman-Andoh, Afua, Welsh, Joshua A , Laws, Maxwell Thomas , Jones, Jennifer , Parney, Ian F. , Brown, Desmond

Mayo Clinic

Neuro-Oncology | November 11, 2023 | Volume: 25 | Issue: Supplement_5 | Pages: v279-v280

10.1093/neuonc/noad179.1075 Get It

Abstract Glioblastoma is the most common primary malignant brain tumor. Despite maximal safe resection, followed by chemoradiation, median survival is 15 months, and 5-year survival is 6.8%. Efficacy of immunotherapy is limited by glioblastoma-mediated immunosuppression. Extracellular vesicles (EVs) are a heterogeneous group of small membrane-bound particles that are released from all cell types. Glioblastoma-derived EVs regulate the tumor microenvironment and tumor progression in a paracrine manner. They also regulate glioblastoma-mediated systemic immunosuppression in an IL6- and PDL1-dependent manner by inducing myeloid-derived suppressor cells (MDSCs) ultimately resulting in T cell depletion. Primary cilia are ubiquitous microtubule-based organelles that project from the mother centriole and are present on glioblastoma cells. Inhibition of ciliogenesis–through knockdown of KIF3A, IFT88, or ARL13B (structural ciliary proteins required for ciliogenesis)–abolishes IL6 induction in response to chemoradiation and significantly reduces the induction of MDSCs in normal human donor monocytes exposed to glioblastoma-derived EVs. Inhibition of ciliogenesis does not affect the biophysical properties of EVs but our data instead suggest significant alterations in EV packaging and content in response to ciliary loss. These data suggest a novel role for primary cilia in packaging of EV contents and connects these organelles with tumor EV-mediated immunosuppression in glioblastomas. These findings have potential implications for improving the efficacy of immunotherapy in glioblastoma–a universally fatal disease.